Search Results - "Ji, Jiansong"

Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles by Qi, Jing, Jin, Feiyang, You, Yuchan, Du, Yan, Liu, Di, Xu, Xiaoling, Wang, Jun, Zhu, Luwen, Chen, Minjiang, Shu, Gaofeng, Wu, Liming, Ji, Jiansong, Du, Yongzhong

“…Some specific chemotherapeutic drugs are able to enhance tumor immunogenicity and facilitate antitumor immunity by inducing immunogenic cell death (ICD)…”
Get full text

One-step rapid quantification of SARS-CoV-2 virus particles via low-cost nanoplasmonic sensors in generic microplate reader and point-of-care device by Huang, Liping, Ding, Longfei, Zhou, Jun, Chen, Shuiliang, Chen, Fang, Zhao, Chen, Xu, Jianqing, Hu, Wenjun, Ji, Jiansong, Xu, Hao, Liu, Gang L.

“…The spread of SARS-CoV-2 virus in the ongoing global pandemic has led to infections of millions of people and losses of many lives. The rapid, accurate and…”
Get full text

Delivery strategies of cancer immunotherapy: recent advances and future perspectives by Zhao, Zhongwei, Zheng, Liyun, Chen, Weiqian, Weng, Wei, Song, Jingjing, Ji, Jiansong

“…Immunotherapy has become an emerging strategy for the treatment of cancer. Immunotherapeutic drugs have been increasing for clinical treatment. Despite…”
Get full text

Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes by Liu, Di, Jin, Feiyang, Shu, Gaofeng, Xu, Xiaoling, Qi, Jing, Kang, Xuqi, Yu, Hui, Lu, Kongjun, Jiang, Saiping, Han, Feng, You, Jian, Du, Yongzhong, Ji, Jiansong

“…Oxidative stress is an important pathological mechanism for acute kidney injury (AKI). SS-31, as a mitochondria-targeted peptide with strong antioxidant…”
Get full text

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma by Tang, Bufu, Zhu, Jinyu, Li, Jie, Fan, Kai, Gao, Yang, Cheng, Shimiao, Kong, Chunli, Zheng, Liyun, Wu, Fazong, Weng, Qiaoyou, Lu, Chenying, Ji, Jiansong

“…In this study, we comprehensively analyzed genes related to ferroptosis and iron metabolism to construct diagnostic and prognostic models and explore the…”
Get full text

Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE by Kong, Chunli, Zhao, Zhongwei, Chen, Weiyue, Lv, Xiuling, Shu, Gaofeng, Ye, Miaoqing, Song, Jingjing, Ying, Xihui, Weng, Qiaoyou, Weng, Wei, Fang, Shiji, Chen, Minjiang, Tu, Jianfei, Ji, Jiansong

“…Objectives To develop and validate a pre-transcatheter arterial chemoembolization (TACE) MRI-based radiomics model for predicting tumor response in…”
Get full text

KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer by Liu, Xinhua, Qiu, Rongfang, Xu, Min, Meng, Miaomiao, Zhao, Siyu, Ji, Jiansong, Yang, Yang

“…Purpose Epigenetic regulation plays critical roles in cancer progression, and high-frequency mutations or expression variations in epigenetic regulators have…”
Get full text

LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1 by Tu, Jianfei, Zhao, Zhongwei, Xu, Min, Chen, Minjiang, Weng, Qiaoyou, Ji, Jiansong

“…•LINC00460 was up-regulated while miR-485-5p was down-regulated in HCC cells.•LINC00460 contributed to HCC progression via sponging miR-485-5p.•PAK1 served as…”
Get full text

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives by Xu, Weiqi, Liu, Ken, Chen, Minjiang, Sun, Jin-Yu, McCaughan, Geoffrey W, Lu, Xiao-Jie, Ji, Jiansong

“…The introduction of immunotherapies has been a major development in the treatment of many advanced cancers, including hepatocellular carcinoma (HCC). We are…”
Get full text

Hippo signaling promotes JNK-dependent cell migration by Ma, Xianjue, Wang, Hongxiang, Ji, Jiansong, Xu, Wenyan, Sun, Yihao, Li, Wenzhe, Zhang, Xiaoping, Chen, Juxiang, Xu, Lei

“…Overwhelming studies show that dysregulation of the Hippo pathway is positively correlated with cell proliferation, growth, and tumorigenesis. Paradoxically,…”
Get full text

Editorial: Radiomics-based theranostics in cancer precision medicine by Ji, Jiansong, Ju, Shenghong, Cai, Wenli

Get full text

Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives by Sun, Jin-Yu, Zhang, Dengke, Wu, Songquan, Xu, Min, Zhou, Xiao, Lu, Xiao-Jie, Ji, Jiansong

“…Abstract PD-1/PD-L1 blockade therapy is a promising cancer treatment strategy, which has revolutionized the treatment landscape of malignancies. Over the last…”
Get full text

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade by Tang, Bufu, Zhu, Jinyu, Liu, Fangming, Ding, Jiayi, Wang, Yajie, Fang, Shiji, zheng, Liyun, Qiu, Rongfang, Chen, Minjiang, Shu, Gaofeng, Xu, Min, Lu, Chenying, Zhao, Zhongwei, Yang, Yang, Ji, Jiansong

“…Colorectal cancer (CRC) is one of the most commonly diagnosed and deadly malignant tumors globally, and its occurrence and progression are closely related to…”
Get full text

Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer by Xu, Min, Zhao, Zhongwei, Song, Jingjing, Lan, Xilin, Lu, Siming, Chen, Minjiang, Wang, Zufei, Chen, Weiqian, Fan, Xiaoxi, Wu, Fazong, Chen, Li, Tu, Jianfei, Ji, Jiansong

“…Emerging evidence implicates an important role for myeloid-derived suppressor cells (MDSCs) in tumor growth, angiogenesis and metastasis. However, limited…”
Get full text

Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma by Lu, Liangji, Jie, Liyong, Zhou, Ying, Zhang, Jiaojiao, Feng, Tingting, Zhu, Yue, Chen, Teng, Zhu, Xiuliang, Ji, Jiansong, Wang, Zuhua

“…This study aims to develop a novel tumor-targeted molecular probe for pancreatic cancer imaging. The objective of this is to prepare a CKAAKN…”
Get more information

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden by Tang, Bufu, Zhu, Jinyu, Zhao, Zhongwei, Lu, Chenying, Liu, Siyu, Fang, Shiji, Zheng, Liyun, Zhang, Nannan, Chen, Minjiang, Xu, Min, Yu, Risheng, Ji, Jiansong

“…[Display omitted] The development and prognosis of HCC involve complex molecular mechanisms, which affect the effectiveness of its treatment strategies. Tumor…”
Get full text

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis by Tang, Bufu, Zhu, Jinyu, Zhang, Baohui, Wu, Fazong, Wang, Yajie, Weng, Qiaoyou, Fang, Shiji, Zheng, Liyun, Yang, Yang, Qiu, Rongfang, Chen, Minjiang, Xu, Min, Zhao, Zhongwei, Ji, Jiansong

“…Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's disease (CD), is a group of chronic and incurable inflammatory diseases…”
Get full text

Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer by Shu, Gaofeng, Chen, Minjiang, Song, Jingjing, Xu, Xiaoling, Lu, Chenying, Du, Yuyin, Xu, Min, Zhao, Zhongwei, Zhu, Minxia, Fan, Kai, Fan, Xiaoxi, Fang, Shiji, Tang, Bufu, Dai, Yiyang, Du, Yongzhong, Ji, Jiansong

“…Hepatic cancer is a serious disease with high morbidity and mortality. Theranostic agents with effective diagnostic and therapeutic capability are highly…”
Get full text

Sialic Acid-Functionalized PEG–PLGA Microspheres Loading Mitochondrial-Targeting-Modified Curcumin for Acute Lung Injury Therapy by Jin, Feiyang, Liu, Di, Yu, Hui, Qi, Jing, You, Yuchan, Xu, Xiaoling, Kang, Xuqi, Wang, Xiaojuan, Lu, Kongjun, Ying, Xiaoying, You, Jian, Du, Yongzhong, Ji, Jiansong

“…Acute lung injury (ALI) is a serious illness without resultful therapeutic methods commonly. Recent studies indicate the importance of oxidative stress in the…”
Get full text

Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer by Zheng, Liyun, Fang, Shiji, Chen, Aifang, Chen, Weiqian, Qiao, Enqi, Chen, Minjiang, Shu, Gaofeng, Zhang, Dengke, Kong, Chunli, Weng, Qiaoyou, Xu, Suqin, Zhao, Zhongwei, Ji, Jiansong

“…Sorafenib, a multikinase inhibitor, is the first-line agent for advanced liver cancer. Sorafenib strongly inhibits both cell proliferation and tumour…”
Get full text